-
1
-
-
84882913986
-
-
Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia, 4th ed. New York, NY: Informa Healthcare USA, 2007
-
Warkentin TE, Greinacher A, eds. Heparin-induced thrombocytopenia, 4th ed. New York, NY: Informa Healthcare USA, 2007
-
-
-
-
2
-
-
0037610515
-
An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients
-
Warkentin TE, Roberts RS, Hirsh J, et al. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003; 163:2518-2524
-
(2003)
Arch Intern Med
, vol.163
, pp. 2518-2524
-
-
Warkentin, T.E.1
Roberts, R.S.2
Hirsh, J.3
-
3
-
-
27144489083
-
Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia
-
Greinacher A, Eichler P, Lietz T, et al. Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia. Blood 2005; 106:2921-2922
-
(2005)
Blood
, vol.106
, pp. 2921-2922
-
-
Greinacher, A.1
Eichler, P.2
Lietz, T.3
-
4
-
-
15944398977
-
Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies
-
Pouplard C, May MA, Regina S, et al. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 2005; 128:837-841
-
(2005)
Br J Haematol
, vol.128
, pp. 837-841
-
-
Pouplard, C.1
May, M.A.2
Regina, S.3
-
5
-
-
27144527501
-
Risk for heparin-induced thrombocytopenia with unfractionated heparin and low-molecular-weight heparin thromboprophylaxis: A meta-analysis
-
Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated heparin and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005; 106:2710-2715
-
(2005)
Blood
, vol.106
, pp. 2710-2715
-
-
Martel, N.1
Lee, J.2
Wells, P.S.3
-
6
-
-
33751161450
-
Gender imbalance and risk factor interactions in heparin-indueed thrombocytopenia
-
Warkentin TE, Sheppard JI, Sigouin CS, et al. Gender imbalance and risk factor interactions in heparin-indueed thrombocytopenia. Blood 2006; 108:2937-2941
-
(2006)
Blood
, vol.108
, pp. 2937-2941
-
-
Warkentin, T.E.1
Sheppard, J.I.2
Sigouin, C.S.3
-
7
-
-
0037832582
-
Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia
-
and the French Heparin-induced Thrombocytopenia Study Group
-
Gruel Y, Pouplard C, Nguyen P, et al, and the French Heparin-induced Thrombocytopenia Study Group. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol 2003; 121:786-792
-
(2003)
Br J Haematol
, vol.121
, pp. 786-792
-
-
Gruel, Y.1
Pouplard, C.2
Nguyen, P.3
-
8
-
-
33749455029
-
Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism
-
Creekmore FM, Oderda GM, Pendleton RC, et al. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism. Pharmacotherapy 2006; 26:1438-1445
-
(2006)
Pharmacotherapy
, vol.26
, pp. 1438-1445
-
-
Creekmore, F.M.1
Oderda, G.M.2
Pendleton, R.C.3
-
9
-
-
34250856863
-
The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital
-
Smythe MA, Koerber JM, Mattson JC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest 2007; 131:1644-1649
-
(2007)
Chest
, vol.131
, pp. 1644-1649
-
-
Smythe, M.A.1
Koerber, J.M.2
Mattson, J.C.3
-
10
-
-
33644745161
-
Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: Diagnostic and therapeutic implications
-
Rauova L, Zhai L, Kowalska MA, et al. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood 2006; 107:2346-2353
-
(2006)
Blood
, vol.107
, pp. 2346-2353
-
-
Rauova, L.1
Zhai, L.2
Kowalska, M.A.3
-
11
-
-
35448956532
-
No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low molecular weight heparin or unfractionated heparin: A meta-analysis
-
Morris TA, Castrejon S, Devendra G, et al. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low molecular weight heparin or unfractionated heparin: a meta-analysis. Chest 2007; 132:1131-1139
-
(2007)
Chest
, vol.132
, pp. 1131-1139
-
-
Morris, T.A.1
Castrejon, S.2
Devendra, G.3
-
12
-
-
33749059398
-
Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies
-
Greinacher A, Gopinadhan M, Guenther JU, et al. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol 2006; 26:2386-2393
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2386-2393
-
-
Greinacher, A.1
Gopinadhan, M.2
Guenther, J.U.3
-
13
-
-
0035283104
-
Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis
-
for the Cortes Investigators
-
Breddin HK, Hach-Wunderle V, Nakov R, et al, for the Cortes Investigators. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001; 344:626-631
-
(2001)
N Engl J Med
, vol.344
, pp. 626-631
-
-
Breddin, H.K.1
Hach-Wunderle, V.2
Nakov, R.3
-
14
-
-
0036049668
-
Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin
-
Lindhoff-Last E, Nakov R, Misselwitz F, et al. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haematol 2002; 118:1137-1142
-
(2002)
Br J Haematol
, vol.118
, pp. 1137-1142
-
-
Lindhoff-Last, E.1
Nakov, R.2
Misselwitz, F.3
|